Research ArticleOriginal Article
Open Access

Quality of life in vitiligo patients in central Saudi Arabia

Sulaiman A. Al-Shammari, Hatim M. Alotaibi, Mohammed A. Assiri, Moataz I. Altokhais, Mazyad S. Alotaibi and Mohammad S. Alkhowailed
Saudi Medical Journal June 2021, 42 (6) 682-687; DOI: https://doi.org/10.15537/smj.2021.42.6.20200833

References

  1. 1.↵
    1. Ezzedine K,
    2. Eleftheriadou V,
    3. Whitton M,
    4. van Geel N.
    Vitiligo. Lancet 2015; 386: 74–84.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Bergqvist C,
    2. Ezzedine K.
    Vitiligo: Areview. Dermatology 2020; 23: 571–592.
    OpenUrl
  3. 3.↵
    1. Amer AA,
    2. Gao XH.
    Quality of life in patients with vitiligo: an analysis of the dermatology life quality index outcome over the past two decades. Int J Dermatol 2016; 55: 608–614.
    OpenUrl
  4. 4.
    1. Grimes PE,
    2. Miller MM.
    Vitiligo: Patient stories, self-esteem, and the psychological burden of disease. Int J Womens Dermatol 2018; 4: 32–37.
    OpenUrl
  5. 5.
    1. Elbuluk N,
    2. Ezzedine K.
    Quality of life, burden of disease, co-morbidities, and systemic effects in vitiligo patients. Dermatol Clin 2017; 35: 117–128.
    OpenUrl
  6. 6.↵
    1. Osinubi O,
    2. Grainge MJ,
    3. Hong L,
    4. Ahmed A,
    5. Batchelor JM,
    6. Grindlay D, et al.
    The prevalence of psychological comorbidity in people with vitiligo: a systematic review and meta-analysis. Br J Dermatol 2018; 178: 863–878.
    OpenUrl
  7. 7.↵
    1. Carr AJ,
    2. Gibson B,
    3. Robinson PG.
    Measuring quality of life: is quality of life determined by expectations or experience? BMJ 2001; 322: 1240–1243.
    OpenUrlFREE Full Text
  8. 8.↵
    1. Whitton ME,
    2. Pinart M,
    3. Batchelor J,
    4. Leonardi-Bee J,
    5. González U,
    6. Jiyad Z, et al.
    Interventions for vitiligo. Cochrane Database Syst Rev 2015: Cd003263.
  9. 9.↵
    1. Finlay AY,
    2. Khan GK.
    Dermatology life quality index (DLQI)--a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210–216.
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    1. Basra MK,
    2. Fenech R,
    3. Gatt RM,
    4. Salek MS,
    5. Finlay AY.
    The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results. Br J Dermatol 2008; 159: 997–1035.
    OpenUrlPubMed
  11. 11.↵
    1. Hongbo Y,
    2. Thomas CL,
    3. Harrison MA,
    4. Salek MS,
    5. Finlay AY.
    Translating the science of quality of life into practice: What do dermatology life quality index scores mean? J Invest Dermatol 2005; 125: 659–564.
    OpenUrlCrossRefPubMedWeb of Science
  12. 12.↵
    1. Chernyshov PV.
    The Evolution of quality of life assessment and use in dermatology. Dermatology 2019; 235: 167–174.
    OpenUrlCrossRef
  13. 13.↵
    1. Bin Saif GA,
    2. Al-Balbeesi AO,
    3. Binshabaib R,
    4. Alsaad D,
    5. Kwatra SG,
    6. Alzolibani AA, et al.
    Quality of life in family members of vitiligo patients: a questionnaire study in Saudi Arabia. Am J Clin Dermatol 2013; 14: 489–495
    OpenUrl
  14. 14.↵
    1. Al-Saeed WY,
    2. Al-Dawood KM,
    3. Bukhari IA,
    4. Bahnassy AA.
    Prevalence and pattern of skin disorders among female schoolchildren in Eastern Saudi Arabia. Saudi Med J 2006; 27: 227–234.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Nanda A,
    2. Al-Hasawi F,
    3. Alsaleh QA.
    A prospective survey of pediatric dermatology clinic patients in Kuwait: an analysis of 10,000 cases. Pediatr Dermatol 1999; 16: 6–11
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    1. Al-Refu K.
    Vitiligo in children: a clinical-epidemiologic study in Jordan. Pediatr Dermatol 2012; 29: 114–115.
    OpenUrlPubMed
  17. 17.↵
    1. Al-Mubarak L,
    2. Al-Mohanna H,
    3. Al-Issa A,
    4. Jabak M,
    5. Mulekar SV.
    Quality of life in Saudi vitiligo patients. J Cutan Aesthet Surg 2011; 4: 33–37.
    OpenUrlPubMed
  18. 18.↵
    1. Al Robaee AA.
    Assessment of Quality of life in Saudi patients with vitiligo in a medical school in Qassim province, Saudi Arabia. Saudi Med J 2007; 28: 1414–1417.
    OpenUrlFREE Full Text
  19. 19.
    1. Krüger C,
    2. Schallreuter KU. Stigmatisation
    , Avoidance Behaviour and Difficulties in coping are common among adult patients with vitiligo. Acta Derm Venereol 2015; 95: 553–558.
    OpenUrl
  20. 20.
    1. Ingordo V,
    2. Cazzaniga S,
    3. Medri M,
    4. Raone B,
    5. Digiuseppe MD,
    6. Musumeci ML, et al.
    To what extent is quality of life impaired in vitiligo? A multicenter study on Italian patients using the dermatology life quality index. Dermatology 2014; 229: 240–247.
    OpenUrl
  21. 21.↵
    1. Karelson M,
    2. Silm H,
    3. Kingo K.
    Quality of life and emotional state in vitiligo in an Estonian sample: comparison with psoriasis and healthy controls. Acta Derm Venereol 2013; 93: 446–450.
    OpenUrl
  22. 22.↵
    1. Welbourn B.
    Comparing Quality of Life in Global Vitiligo Populations. The University of Arizona, 2018. [Updated 2021. Accessed 2020 December 14]. Available from: https://repository.arizona.edu/bitstream/handle/10150/626905/WelbournB_Poster.pdf?sequence=3&isAllowed=y
  23. 23.↵
    1. Ingordo V,
    2. Cazzaniga S,
    3. Gentile C,
    4. Iannazzone SS,
    5. Cusano F,
    6. Naldi L.
    Dermatology life quality index score in vitiligo patients: a pilot study among young Italian males. G Ital Dermatol Venereol 2012; 147: 83–90.
    OpenUrlPubMed
  24. 24.↵
    1. Ongenae K,
    2. Dierckxsens L,
    3. Brochez L,
    4. van Geel N,
    5. Naeyaert JM.
    Quality of life and stigmatization profile in a cohort of vitiligo patients and effect of the use of camouflage. Dermatology 2005; 210: 279–285.
    OpenUrlCrossRefPubMedWeb of Science
  25. 25.↵
    1. Ramakrishna P,
    2. Rajni T.
    Psychiatric morbidity and quality of life in vitiligo patients. Indian J Psychol Med 2014; 36: 302–303.
    OpenUrl
  26. 26.↵
    1. AlShahwan MA.
    The prevalence of anxiety and depression in arab dermatology patients. J Cutan Med Surg 2015;19: 297–303.
    OpenUrlCrossRefPubMed
  27. 27.↵
    1. AlGhamdi KM.
    Beliefs and perceptions of Arab vitiligo patients regarding their condition. Int J Dermatol 2010; 49:1141–1145.
    OpenUrlCrossRefPubMed
  28. 28.↵
    1. Simons RE,
    2. Zevy DL,
    3. Jafferany M.
    Psychodermatology of vitiligo: psychological impact and consequences. Dermatol Ther 2020; 33: e13418.
    OpenUrl
  29. 29.↵
    1. Papadopoulos L,
    2. Bor R,
    3. Legg C.
    Coping with the disfiguring effects of vitiligo: a preliminary investigation into the effects of cognitive-behavioural therapy. Br J Med Psychol 1999; 72: 385–396.
    OpenUrlCrossRefPubMed
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section

Keywords